This week's View covers a study that applied the 2019 European Society of Cardiology and European Atherosclerosis Society guidelines to data of patients with recent myocardial infarction (MI) and a study on the time trends of in-hospital and out-of-hospital bleeding parallel to the development of new treatments and ischemic outcomes over the last 20 years in a nationwide MI population.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Anticoagulation Management and ACS, Lipid Metabolism, Nonstatins, Novel Agents, Primary Hyperlipidemia, Statins

Keywords: EaglesEyeView, Acute Coronary Syndrome, Anticoagulants, Atherosclerosis, Blood Transfusion, Cholesterol, LDL, Dyslipidemias, Fibrinolytic Agents, Hemorrhage, Hospitalization, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperlipoproteinemia Type II, Inflammation, Life Style, Myocardial Infarction, Myocardial Ischemia, Patient Discharge, Platelet Aggregation Inhibitors, Primary Prevention, Proprotein Convertases, Stroke, Subtilisins, Vascular Diseases, Metabolic Syndrome

< Back to Listings